MediSafe
-
StartUPDATES: New Developments from Healthcare Startups
Check out new developments from Medvantx, Medisafe, Medical Informatics Corp., Journey Biosciences, and GSR Ventures.
-
Could pharma, digital therapeutics partnerships be a $1B opportunity?
A panel discussion at the DTx East conference in Boston discussed whether partnerships between digital health and drugmakers were “a match made in heaven.”
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
What are the challenges and opportunities of running clinical trials of digital therapeutics?
Digital therapeutics clinical trials enable collection and analysis of data in real time, but considerations like standardization of analysis, trial endpoints and placebo controls are critical, experts at the DTx East conference in Boston said.
-
AmerisourceBergen’s Lash Group teams up with Medisafe to address patient adherence
Through their alliance, Medisafe will deliver real-time interventions to help patients stay adherent and will alert Lash Group’s clinicians when patients are considered “at-risk.”
-
Chronic disease management company Livongo boosts platform with new device and data capabilities
The new offerings are part of the company’s evolution to what it calls Applied Health Signals, a shorthand to describe their platform’s combination of data science and contextually relevant behavior change tools.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Medisafe expands medication adherence research service for pharma and life science customers
The expanded service is designed to provide pharma companies with information that can help inform new strategies and tactics to improve patient engagement.
-
Medisafe raises $14.5M and adds London office to reflect growth in Europe
New European investor Octopus Ventures led the Series B round with participation from another new backer, M Ventures — the Amsterdam-based, strategic, corporate venture capital arm of Merck KGaA, in Darmstadt, Germany
-
When is medication adherence at its best (and worst)?
A Medisafe infographic illustrates how the digital health startup is using de-identified data to visualize when people are most and least likely to take their medication.
-
Pharma companies gain access to de-identified data on adherence for specific drugs
Medisafe’s new channel for pharma companies is aimed at helping drug developers better understand adherence dynamics and make it easier to tweak their guidance for patients and physicians.
-
Medisafe teams with Nestlé for pre-surgery nutrition reminders
In some ways, it’s a thinly veiled ad campaign for Nestlé’s pre-surgery nutrition drink, but it’s also a way to engage patients to help prevent surgical infections.
-
Medisafe-IMS Health study shows boost in adherence from digital health tool (infographic)
Study suggests the impact that digital health can have on chronic conditions.